In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligands
- PMID: 31753695
- PMCID: PMC11659960
- DOI: 10.1016/j.bmcl.2019.126785
In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligands
Abstract
Altered dynamics of microtubules (MT) are implicated in the pathophysiology of a number of brain diseases. Therefore, radiolabeled MT targeted ligands that can penetrate the blood brain barrier (BBB) may offer a direct and sensitive approach for diagnosis, and assessing the clinical potential of MT targeted therapeutics using PET imaging. We recently reported two BBB penetrating radioligands, [11C]MPC-6827 and [11C]HD-800 as specific PET ligands for imaging MTs in brain. The major metabolic pathway of the above molecules is anticipated to be via the initial labeling site, O-methyl, compared to the N-methyl group. Herein, we report the radiosynthesis of N-11CH3-MPC-6827 and N-11CH3-HD-800 and a comparison of their in vivo binding with the corresponding O-11CH3 analogues using microPET imaging and biodistribution methods. Both O-11CH3 and N-11CH3 labeled MT tracers exhibit high specific binding and brain. The N-11CH3 labeled PET ligands demonstrated similar in vivo binding characteristics compared with the corresponding O-11CH3 labeled tracers, [11C]MPC-6827 and [11C]HD-800 respectively.
Keywords: Brain; Microtubule; PET; Radiotracer; Tubulin.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest
J John Mann receives royalties for commercial use of the C-SSRS from the Research Foundation of Mental Hygiene. All other authors delcare that no conflict of interest.
Figures
References
-
- Nogales E Structural insights into microtubule function. Ann Rev Biochent. 2010;69:277–302. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
